Category: CovidienSyndicate content

FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried

August 7, 2014 by Arezu Sarvestani

Despite the furor on Capitol Hill, lawmakers aren't likely to produce reform that will hinder Medtronic's $43 billion acquisition of Covidien, according to Morgan Stanley analysts.

Analyst report: Dems can't stop Medtronic-Covidien merger

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Lack of FDA approval is no longer a deal-breaker for a big exit | The week in medtech M&A

August 6, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Report: Medtech M&A exits don't hinge on FDA approval; White House rails against Medtronic-style corporate inversions; Smith & Nephew CEO: We've been an M&A target for 10 years; More mega-merger talk from medtech giants; Baxter sheds vaccines biz for $635M

Report: Medtech M&A exits don't hinge on FDA approval

July 31, 2014 by Arezu Sarvestani

Report: Medtech M&A no longer hinges on FDA approval

Details of the mega-merger: Covidien makes the 1st move, Almeida prepares to step down

August 6, 2014 by Arezu Sarvestani

Covidien discloses details of the pending $43 billion acquisition by Medtronic, including who approached who and what Covidien chief Jose Almeida will do after handing the reins to Medtronic.

Medtronic and Covidien open up about $43B mega-merger

Congress moves to punish Medtronic and other 'corporate deserters'

August 5, 2014 by Arezu Sarvestani

Democrats in the Senate and House push a measure to withhold federal contracts from companies that move their headquarters overseas to find better corporate tax rates.

Senate moves to punish Medtronic and other 'corporate deserts'

A handful of Democrats in Congress are hoping to curb a corporate exodus by threatening to withhold federal contracts from firms that shift their headquarters overseas to benefit from lower tax rates.

Medtronic, Covidien merger: Ishrak and Almeida go on tour

August 5, 2014 by Arezu Sarvestani

The chiefs of Medtronic and Covidien hit the road to visit a slew of company sites and talk business as the medtech titans prepare to merge.

Ishrak and Almeida go on tour

Medtronic's Omar Ishrak testing devices with with Gene Stellon, R&D VP at Covidien.

Medtech trends: The most talked about device makers in July 2014

August 5, 2014 by Arezu Sarvestani

MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.

chart

Click to enlarge.

MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.

White House rails against Medtronic-style corporate inversions | MassDevice.com On Call

August 1, 2014 by Arezu Sarvestani

President Barack Obama condemns corporate inversions, like the one Medtronic's planning in its mega-merger with Covidien, saying that companies are "renouncing their citizenship" in order to dodge taxes.

MassDevice.com On Call

MASSDEVICE ON CALL — President Barack Obama took time in this weeks' regular address to criticize the wave of "corporate inversions," in which companies, such as Medtronic (NYSE:MDT), are using outside-U.S. acquisitions to shift their headquarters overseas.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp